Tofogliflozin, a novel and selective SGLT2 inhibitor improves glycemic control and lowers body weight in patients with type 2 diabetes mellitus inadequately. Reference standards of Tofogliflozin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Tofogliflozin-d5
Catalogue No.:PA STI 083570
CAS :
Molecular Formula : C22H21D5O6
Molecular Weight : 391.47
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
